Antibodies News and Research

RSS

Study suggests safer immunization approach to Alzheimer's

Researchers at the University of Illinois at Chicago have had preliminary success with a method of immunization intended to dissolve the plaques in brain tissue that are associated with Alzheimer's disease.

28 Oct 2004

Easy-to-make vaccine tackles a range of illnesses

Australian researchers have created a totally synthetic vaccine that is effective against viruses, harmful bacteria and tumours and could lead to a powerful new arsenal of vaccines for humans and animals.

26 Oct 2004

Genetic double-agents unmasked

Babraham Institute and Cancer Research UK scientists have discovered that certain enzymes with a key activity in the immune system may be important in stem-cell development, but may also work against us by contributing to the occurrence of cancer.

26 Oct 2004

Scientists are testing the effectiveness of a new type of flu vaccine

The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.

25 Oct 2004

New oral vaccine treatment is effective in reducing Alzheimer's disease pathology

Alzheimer's disease is characterized by progressive loss of cognitive function due to amyloid-beta (Aß) deposits in the central nervous system. If these deposits could be stopped or slowed, Alzheimer's disease might become more manageable.

25 Oct 2004

Breakthrough discovery in treating narrowed arteries

A breakthrough discovery by Heart and Stroke Foundation researcher Dr. Michael Kutryk that harnesses the body’s own natural defenses to fight narrowing of the arteries has been recognized as “a glimpse into the future” and “potentially one of the biggest advances in cardiology to date”.

25 Oct 2004

Lag-3 gene dampens immune responses by controlling regulatory T-cell function

The discovery that the Lag-3 gene acts as a brake to prevent immune system responses from running out of control solves a mystery that has puzzled researchers since the gene was discovered 14 years ago.

22 Oct 2004

Genetic research offers insight into Sjögren's syndrome and the general developmental machinery of the immune system

By knocking out a single gene in mice, immunologists at Duke University Medical Center have mimicked a little-understood autoimmune disorder in humans.

21 Oct 2004

Babies born by Caesarean section may be at greater risk of diarrhoea

Babies born by Caesarean section may be at greater risk of diarrhoea and sensitisation to certain foodstuffs during their first 12 months than babies born vaginally, suggests research in the Archives of Disease in Childhood.

21 Oct 2004

New antibody to prevent respiratory syncytial virus in premature babies

Virginia Commonwealth University researchers are studying the effectiveness of introducing a new antibody in premature infants to manage the most common form of lower respiratory tract infections in children worldwide.

21 Oct 2004

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Rheumatoid arthritis patients have an approximately two-fold increased morbidity and mortality in infections compared to a population without the disease.

18 Oct 2004

Malaria vaccine candidate looks extremely promising

In a proof-of-concept study published this week in The Lancet, researchers report that GlaxoSmithKline's RTS,S/AS02A malaria vaccine candidate protected a significant percentage of children against uncomplicated malaria, infection, and even severe forms of the disease for at least six months.

16 Oct 2004

Wisconsin has identified its first laboratory confirmed case of influenza this season

Public health officials in the department said the case, confirmed by the Wisconsin State Laboratory of Hygiene to be influenza type A (H3 subtype), involves an adult female from Waupaca County.

13 Oct 2004

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

MedImmune has announced that data from a preclinical study for its lead vaccine candidate to prevent respiratory syncytial virus (RSV) and parainfluenza virus type-3 (PIV-3) has shown a protective immune response against both viruses in animals.

13 Oct 2004

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

Flu shots have been around since World War II, and the Centers for Disease Control and Prevention has long recommended shots as a way to prevent influenza in the elderly. The approval of a new nasal spray vaccine begs the question whether those looking to stave off the flu should stick with the tried and true injection or switch to the nasal spray.

13 Oct 2004

Researchers have identified a protein in the inner ear that translates sound into the nerve impulses used by the brain

Researchers at Harvard Medical School and their colleagues report in the October 13 Nature advanced on-line edition that they have identified a protein deep in the inner ear that they believe translates sound into the nerve impulses used by the brain.

13 Oct 2004

Protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain

A protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain by transporting this agent back into the bloodstream, thus reducing the ability of this agent to reach tumors.

11 Oct 2004

Bionanotechnology that combines the strengths of nanotechnology and biochemistry to generate a new type of bionanomaterial

A team of University of Florida researchers has created tiny hybrid particles that can speedily root out even one isolated E. coli bacterium lurking in ground beef or provide a crucial early warning alarm for bacteria used as agents of bioterrorism and for early disease diagnosis.

11 Oct 2004

Researchers suggest how to generate B cells from stem cells

Before stem cells, of whatever origin, can be used to treat patients, scientists will need to learn how to coax them to develop into the desired cell types, a major challenge.

11 Oct 2004

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

United States Department of Health and Human Services has announced four new contracts totaling more than $232 million to fund development of new vaccines against three potential agents of bioterrorism: smallpox, plague and tularemia. The National Institute of Allergy and Infectious Diseases (NIAID), will administer the contracts.

8 Oct 2004

Antibodies News and Research

Study suggests safer immunization approach to Alzheimer's

Easy-to-make vaccine tackles a range of illnesses

Genetic double-agents unmasked

Scientists are testing the effectiveness of a new type of flu vaccine

New oral vaccine treatment is effective in reducing Alzheimer's disease pathology

Breakthrough discovery in treating narrowed arteries

Lag-3 gene dampens immune responses by controlling regulatory T-cell function

Genetic research offers insight into Sjögren's syndrome and the general developmental machinery of the immune system

Babies born by Caesarean section may be at greater risk of diarrhoea

New antibody to prevent respiratory syncytial virus in premature babies

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Malaria vaccine candidate looks extremely promising

Wisconsin has identified its first laboratory confirmed case of influenza this season

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

Researchers have identified a protein in the inner ear that translates sound into the nerve impulses used by the brain

Protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain

Bionanotechnology that combines the strengths of nanotechnology and biochemistry to generate a new type of bionanomaterial

Researchers suggest how to generate B cells from stem cells

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

Immunology eBook

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest Life Science News